SCHEMBL220433

SCHEMBL220433

CN1C(C)(C)CC(OC(=O)C(CCCCCCOc2ccc(O)cc2)(Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C(=O)OC2CC(C)(C)N(C)C(C)(C)C2)CC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT3 P36888 1/20 0.33
NR5A1 Q13285 1/20 0.32
ESR1 P03372 2/20 0.32
ESR2 Q92731 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
BLM P54132 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741112 0.94 CSF1R (0.32) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL223193 0.93 SLC2A1 (0.41) MEN1KMT2AALDH1A1NPSR1SLC2A1
SCHEMBL223143 0.90 ATM (0.36) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL223144 0.90 ATM (0.36) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL222324 0.89 NPC1 (0.33) CYP1A2CYP3A4CYP2D6MAPTHRH3
SCHEMBL222202 0.88 NPC1 (0.33) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL2789383 0.87 CSF1R (0.30) CSF1RPDGFRBKITPDGFRAFLT3
SCHEMBL11213179 0.86 GAA (0.35) MEN1KMT2AUSP2ALDH1A1CYP1A2
SCHEMBL28578189 0.86 KMT2A (0.36) MEN1KMT2AUSP2ALDH1A1CYP1A2
SCHEMBL222304 0.86 ALDH1A1 (0.36) MEN1KMT2AUSP2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431039-B2 Mesogenic stabilizers TRANSITIONS OPTICAL, INC. (US) 2013-04-30 US disclosed
US-20120002141-A1 MESOGENIC STABILIZERS TRANSITIONS OPTICAL, INC. (US) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120002141-A1 MESOGENIC STABILIZERS BMI1, METTL14, PYM1 CSF1R 1055/4885PDGFRB 3036/4885KIT 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.